Paper15535832
Collagen type II (CII)-specific antibodies induce arthritis in the absence of T or B cells but the arthritis progression is enhanced by CII-reactive T cells.
Nandakumar KS and 3 others. Arthritis Res Ther, 2004. Cited by 111 papers, by iCite.
Cite this record
ConductScience Library. Collagen type II (CII)-specific antibodies induce arthritis in the absence of T or B cells but the arthritis progression is enhanced by CII-reactive T cells. Papers, record 15535832. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/15535832
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Collagen type II (CII)-specific antibodies induce arthritis in the absence of T or B cells but the arthritis progression is enhanced by CII-reactive T cells.
- PubMed
Topics26
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antibodies, Monoclonal | Major topic |
| Arthritis, Experimental | Major topic |
| Collagen Type II | Major topic |
| Epitopes, T-Lymphocyte | Major topic |
| T-Lymphocyte Subsets | Major topic |
| Adoptive Transfer | |
| Animals | |
| Antibody Specificity | |
| B-Lymphocytes | |
| Crosses, Genetic | |
| Disease Progression | |
| Female | |
| Glycosylation | |
| Histocompatibility Antigens Class II | |
| Immunity, Cellular | |
| Immunization, Passive | |
| Immunologic Deficiency Syndromes | |
| Male | |
| Mice | |
| Mice, Inbred C3H | |
| Mice, Inbred C57BL | |
| Mice, Inbred DBA | |
| Mice, Knockout | |
| Protein Processing, Post-Translational | |
| Rats | |
| Receptors, Antigen, T-Cell, alpha-beta |
Source PubMed
References34
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 11352257 | Chronic relapsing homologous collagen-induced arthritis in DBA/1 mice as a model for testing disease-modifying and remission-inducing therapies. | Arthritis Rheum | 2001 | https://conductscience.org/library/papers/11352257 | PubMed |
| 2 | 10383939 | Collagen-induced arthritis development requires alpha beta T cells but not gamma delta T cells: studies with T cell-deficient (TCR mutant) mice. | Int Immunol | 1999 | https://conductscience.org/library/papers/10383939 | PubMed |
| 3 | 11961557 | RANKL maintains bone homeostasis through c-Fos-dependent induction of interferon-beta. | Nature | 2002 | https://conductscience.org/library/papers/11961557 | PubMed |
| 4 | 12093872 | Critical roles for interleukin 1 and tumor necrosis factor alpha in antibody-induced arthritis. | J Exp Med | 2002 | https://conductscience.org/library/papers/12093872 | PubMed |
| 5 | 12133972 | The importance of IL-1 beta and TNF-alpha, and the noninvolvement of IL-6, in the development of monoclonal antibody-induced arthritis. | J Immunol | 2002 | https://conductscience.org/library/papers/12133972 | PubMed |
| 6 | 12355481 | Epitope-specific recognition of type II collagen by rheumatoid arthritis antibodies is shared with recognition by antibodies that are arthritogenic in collagen-induced arthritis in the mouse. | Arthritis Rheum | 2002 | https://conductscience.org/library/papers/12355481 | PubMed |
| 7 | 12355448 | IL-4-deficient mice develop less acute but more chronic relapsing collagen-induced arthritis. | Eur J Immunol | 2002 | https://conductscience.org/library/papers/12355448 | PubMed |
| 8 | 12438440 | Osteoclasts are essential for TNF-alpha-mediated joint destruction. | J Clin Invest | 2002 | https://conductscience.org/library/papers/12438440 | PubMed |
| 9 | 12591906 | Prevention of arthritis by interleukin 10-producing B cells. | J Exp Med | 2003 | https://conductscience.org/library/papers/12591906 | PubMed |
| 10 | 12884302 | Induction of arthritis by single monoclonal IgG anti-collagen type II antibodies and enhancement of arthritis in mice lacking inhibitory FcgammaRIIB. | Eur J Immunol | 2003 | https://conductscience.org/library/papers/12884302 | PubMed |
| 11 | 14500645 | Genetic control of tolerance to type II collagen and development of arthritis in an autologous collagen-induced arthritis model. | J Immunol | 2003 | https://conductscience.org/library/papers/14500645 | PubMed |
| 12 | 14578183 | Collagen type II-specific monoclonal antibody-induced arthritis in mice: description of the disease and the influence of age, sex, and genes. | Am J Pathol | 2003 | https://conductscience.org/library/papers/14578183 | PubMed |
| 13 | 14734614 | Analysis of autoreactive T cells associated with murine collagen-induced arthritis using peptide-MHC multimers. | Int Immunol | 2004 | https://conductscience.org/library/papers/14734614 | PubMed |
| 14 | 14871534 | Measurement of antibodies to collagen II by inhibition of collagen fibril formation in vitro. | J Immunol Methods | 2004 | https://conductscience.org/library/papers/14871534 | PubMed |
| 15 | 894190 | Autoimmunity to type II collagen an experimental model of arthritis. | J Exp Med | 1977 | https://conductscience.org/library/papers/894190 | PubMed |
| 16 | 7319558 | Collagen-induced arthritis in the rat: modification of immune and arthritic responses by free collagen and immune anti-collagen antiserum. | Immunology | 1981 | https://conductscience.org/library/papers/7319558 | PubMed |
| 17 | 3928802 | Prevention of type II collagen-induced arthritis by in vivo treatment with anti-L3T4. | J Exp Med | 1985 | https://conductscience.org/library/papers/3928802 | PubMed |
| 18 | 2413528 | T lymphocytes in collagen II-induced arthritis in mice. Characterization of arthritogenic collagen II-specific T-cell lines and clones. | Scand J Immunol | 1985 | https://conductscience.org/library/papers/2413528 | PubMed |
| 19 | 3947407 | Homologous type II collagen induces chronic and progressive arthritis in mice. | Arthritis Rheum | 1986 | https://conductscience.org/library/papers/3947407 | PubMed |
| 20 | 2421741 | Characterization of the antibody response in mice with type II collagen-induced arthritis, using monoclonal anti-type II collagen antibodies. | Arthritis Rheum | 1986 | https://conductscience.org/library/papers/2421741 | PubMed |
Cited by57
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 111 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42983569 | Vinpocetine ameliorates bone erosion and joint inflammation in rheumatoid arthritis via suppression of NLRP3 inflammasome. | Biol Direct | 2026 | https://conductscience.org/library/papers/42983569 | PubMed |
| 42941807 | Preclinical Mouse Models of Rheumatoid Arthritis: Comparative Insights into Inflammatory Mediators and Immune Cells. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42941807 | PubMed |
| 42609370 | Peedanil Gold attenuates IL-6-mediated articular pathologies in a collagen antibody-induced murine model of rheumatoid arthritis. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42609370 | PubMed |
| 42510675 | Murine and Humanized Mouse Models in Autoimmune Disease Research and Therapeutics Development. | Biology (Basel) | 2026 | https://conductscience.org/library/papers/42510675 | PubMed |
| 41613106 | Fc-enhanced anti-CCR6 antibody elicits robust therapeutic effects across multiple autoimmune diseases. | Front Immunol | 2025 | https://conductscience.org/library/papers/41613106 | PubMed |
| 41197961 | Matrix metalloproteinase 13 (MMP-13) processing of type II collagen is altered by antibodies and citrullination found in the early stages of rheumatoid arthritis. | Matrix Biol | 2025 | https://conductscience.org/library/papers/41197961 | PubMed |
| 40725063 | The Therapeutic Potential of Phytochemicals Unlocks New Avenues in the Management of Rheumatoid Arthritis. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40725063 | PubMed |
| 39632992 | The need for Cre-loci controls in conditional mouse experiments: Mrp8-cre transgene predisposes mice to antibody-induced arthritis. | Genes Immun | 2025 | https://conductscience.org/library/papers/39632992 | PubMed |
| 37741824 | A subset of type-II collagen-binding antibodies prevents experimental arthritis by inhibiting FCGR3 signaling in neutrophils. | Nat Commun | 2023 | https://conductscience.org/library/papers/37741824 | PubMed |
| 37542341 | Transgenic disruption of endogenous glucocorticoid signaling in osteoblasts does not alter long-term K/BxN serum transfer-induced arthritis. | Arthritis Res Ther | 2023 | https://conductscience.org/library/papers/37542341 | PubMed |
| 37307481 | Therapy targeting antigen-specific T cells by a peptide-based tolerizing vaccine against autoimmune arthritis. | Proc Natl Acad Sci U S A | 2023 | https://conductscience.org/library/papers/37307481 | PubMed |
| 37039837 | Inactivation of the gene encoding procalcitonin prevents antibody-mediated arthritis. | Inflamm Res | 2023 | https://conductscience.org/library/papers/37039837 | PubMed |
| 36411592 | The use of animal models in rheumatoid arthritis research. | J Yeungnam Med Sci | 2023 | https://conductscience.org/library/papers/36411592 | PubMed |
| 36397156 | EC-18 prevents autoimmune arthritis by suppressing inflammatory cytokines and osteoclastogenesis. | Arthritis Res Ther | 2022 | https://conductscience.org/library/papers/36397156 | PubMed |
| 36009497 | β2-Adrenergic Receptor Expression and Intracellular Signaling in B Cells Are Highly Dynamic during Collagen-Induced Arthritis. | Biomedicines | 2022 | https://conductscience.org/library/papers/36009497 | PubMed |
| 35967383 | An update on Ym1 and its immunoregulatory role in diseases. | Front Immunol | 2022 | https://conductscience.org/library/papers/35967383 | PubMed |
| 35242136 | Proteus mirabilis Vesicles Induce Mitochondrial Apoptosis by Regulating miR96-5p/Abca1 to Inhibit Osteoclastogenesis and Bone Loss. | Front Immunol | 2022 | https://conductscience.org/library/papers/35242136 | PubMed |
| 35069529 | Overload of the Temporomandibular Joints Accumulates γδ T Cells in a Mouse Model of Rheumatoid Arthritis: A Morphological and Histological Evaluation. | Front Immunol | 2021 | https://conductscience.org/library/papers/35069529 | PubMed |
| 35036874 | The calcitonin receptor protects against bone loss and excessive inflammation in collagen antibody-induced arthritis. | iScience | 2022 | https://conductscience.org/library/papers/35036874 | PubMed |
| 34552089 | Polymorphic estrogen receptor binding site causes Cd2-dependent sex bias in the susceptibility to autoimmune diseases. | Nat Commun | 2021 | https://conductscience.org/library/papers/34552089 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/15535832
GET https://conductscience.org/api/papers/v1/15535832/references?page=2